tirzepatide and anxiety Can cause anxiety? What the clinical evidence actually shows GLP-1s associated with reduced risk
Description
Many people still begin at 0.250.5 mg to minimise GI symptoms
Discontinue the medication and seek medical attention immediately if you observe severe abdominal pain, vomiting, fever, or jaundice
doi: 10.1016/j.clinthera.2015.05.511
It is important to keep in mind that neither of these drugs offers a quick fix for weight loss
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that improves glycemic control and promotes weight loss
